Biopharmaceutics and Drug Disposition
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.2 | Q3 | 35.4% | 0.540 | Q2 | 63.9% |
| 2024 | 2.0 | Q3 | 34.6% | 0.589 | Q2 | 67.9% |
| 2023 | 1.7 | Q3 | 30.4% | 0.396 | Q2 | 57.5% |
| 2022 | 2.1 | Q4 | 35.1% | 0.421 | Q2 | 60.9% |
| 2021 | 1.8 | Q4 | 34.8% | 0.335 | Q2 | 54.9% |
| 2020 | — | — | 0.419 | Q2 | 61.0% | |
| 2019 | — | — | 0.544 | Q2 | 69.8% | |
| 2018 | — | — | 0.456 | Q2 | 62.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0142-2782
ISSN
1099-081X
region
Western Europe
coverage
1979-2026